We are live on
!
Find out more
VCM
Voleon Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
56.94%
This Fund
S&P 500
This Quarter
Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
(+18%)
Cap. Flow
+$57M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$41.2M |
| 3 |
Merck
MRK
|
+$26.1M |
| 4 |
Intuit
INTU
|
+$24.7M |
| 5 |
AstraZeneca
AZN
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$29.3M |
| 2 |
Qualcomm
QCOM
|
+$28.6M |
| 3 |
Fortinet
FTNT
|
+$26.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$22.1M |
| 5 |
Eli Lilly
LLY
|
+$20.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.25% |
| 2 | Financials | 12.04% |
| 3 | Healthcare | 11.39% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 10.44% |
Similar funds
GCM
ACM
GCM
SCM
NC
EI
MC
AP
Voleon Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
- Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
- Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
- Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
- Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
- Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
- Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.
Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.